• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MPAM临床前候选药物开发中的挑战:一系列氮杂环丁烷衍生的叔酰胺的发现、构效关系及生物学特性

Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides.

作者信息

Tarr James C, Wood Michael R, Noetzel Meredith J, Melancon Bruce J, Lamsal Atin, Luscombe Vincent B, Rodriguez Alice L, Byers Frank W, Chang Sichen, Cho Hyekyung P, Engers Darren W, Jones Carrie K, Niswender Colleen M, Wood Michael W, Brandon Nicholas J, Duggan Mark E, Conn P Jeffrey, Bridges Thomas M, Lindsley Craig W

机构信息

Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Chemistry, Vanderbilt University, Nashville, TN 37232, USA.

出版信息

Bioorg Med Chem Lett. 2017 Dec 1;27(23):5179-5184. doi: 10.1016/j.bmcl.2017.10.053. Epub 2017 Oct 24.

DOI:10.1016/j.bmcl.2017.10.053
PMID:29089231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6542369/
Abstract

Herein we describe the continued optimization of M positive allosteric modulators (PAMs) within the 5-amino-thieno[2,3-c]pyridazine series of compounds. In this letter, we disclose our studies on tertiary amides derived from substituted azetidines. This series provided excellent CNS penetration, which had been challenging to consistently achieve in other amide series. Efforts to mitigate high clearance, aided by metabolic softspot analysis, were unsuccessful and precluded this series from further consideration as a preclinical candidate. In the course of this study, we found that potassium tetrafluoroborate salts could be engaged in a tosyl hydrazone reductive cross coupling reaction, a previously unreported transformation, which expands the synthetic utility of the methodology.

摘要

在此,我们描述了5-氨基噻吩并[2,3-c]哒嗪系列化合物中M阳性变构调节剂(PAMs)的持续优化。在这封信中,我们披露了对源自取代氮杂环丁烷的叔酰胺的研究。该系列具有出色的中枢神经系统渗透性,而在其他酰胺系列中一直难以持续实现这一点。借助代谢软点分析减轻高清除率的努力未成功,因此该系列不再作为临床前候选药物进一步考虑。在本研究过程中,我们发现四氟硼酸钾盐可参与甲苯磺酰腙还原交叉偶联反应,这是一种以前未报道的转化反应,扩展了该方法的合成应用。

相似文献

1
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides.MPAM临床前候选药物开发中的挑战:一系列氮杂环丁烷衍生的叔酰胺的发现、构效关系及生物学特性
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5179-5184. doi: 10.1016/j.bmcl.2017.10.053. Epub 2017 Oct 24.
2
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides.MPAM临床前候选药物开发中的挑战:一系列3-氨基氮杂环丁烷衍生酰胺的发现、构效关系及体内特性研究
Bioorg Med Chem Lett. 2017 Jul 1;27(13):2990-2995. doi: 10.1016/j.bmcl.2017.05.014. Epub 2017 May 6.
3
Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M positive allosteric modulator (PAM) chemotype via scaffold hopping.通过骨架跃迁发现一种新型2,4-二甲基喹啉-6-甲酰胺M正变构调节剂(PAM)化学类型。
Bioorg Med Chem Lett. 2017 Nov 15;27(22):4999-5001. doi: 10.1016/j.bmcl.2017.10.016. Epub 2017 Oct 9.
4
Discovery of a novel 3,4-dimethylcinnoline carboxamide M positive allosteric modulator (PAM) chemotype via scaffold hopping.通过骨架跃迁发现一种新型3,4-二甲基喹喔啉甲酰胺M正变构调节剂(PAM)化学类型。
Bioorg Med Chem Lett. 2019 Nov 1;29(21):126678. doi: 10.1016/j.bmcl.2019.126678. Epub 2019 Sep 10.
5
Challenges in the development of an M PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs.开发一种体内 M PAM 工具化合物的挑战:VU0467154 的发现及紧密类似物意外的药物代谢动力学特征。
Bioorg Med Chem Lett. 2017 Jan 15;27(2):171-175. doi: 10.1016/j.bmcl.2016.11.086. Epub 2016 Nov 30.
6
Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core.基于5,6-二甲基-4-(哌啶-1-基)噻吩并[2,3-d]嘧啶核心的新型系列高中枢神经系统渗透性M4型正变构调节剂的发现与优化
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3029-3033. doi: 10.1016/j.bmcl.2016.05.010. Epub 2016 May 5.
7
Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M positive allosteric modulator (PAM) chemotype.发现一种新型 2,3-二甲基咪唑并[1,2-a]吡嗪-6-甲酰胺 M 正变构调节剂(PAM)化学型。
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126812. doi: 10.1016/j.bmcl.2019.126812. Epub 2019 Nov 13.
8
Novel M positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.源自对假定的β-氨基酰胺类配体分子内氢键模式的作用和影响提出质疑的新型 M 阳性变构调节剂。
Bioorg Med Chem Lett. 2019 Feb 1;29(3):362-366. doi: 10.1016/j.bmcl.2018.12.039. Epub 2018 Dec 18.
9
VU6005806/AZN-00016130, an advanced M positive allosteric modulator (PAM) profiled as a potential preclinical development candidate.VU6005806/AZN - 00016130,一种先进的M阳性变构调节剂(PAM),被评估为潜在的临床前开发候选药物。
Bioorg Med Chem Lett. 2019 Jul 15;29(14):1714-1718. doi: 10.1016/j.bmcl.2019.05.026. Epub 2019 May 16.
10
Discovery of structurally distinct tricyclic M positive allosteric modulator (PAM) chemotypes.发现结构独特的三环 M 型正变构调节剂(PAM)化合物类型。
Bioorg Med Chem Lett. 2020 Feb 15;30(4):126811. doi: 10.1016/j.bmcl.2019.126811. Epub 2019 Nov 11.

引用本文的文献

1
Discovery of Pre-Clinical Candidate /: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy.临床前候选药物的发现:一种高选择性、口服生物可利用且结构独特的三环M型毒蕈碱乙酰胆碱受体正向变构调节剂(PAM),具有强大的体内疗效。
ACS Chem Neurosci. 2025 Jun 4;16(11):2141-2162. doi: 10.1021/acschemneuro.5c00277. Epub 2025 May 26.
2
Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM).VU6016235的发现:一种高选择性、口服生物可利用且结构独特的三环M型毒蕈碱乙酰胆碱受体正变构调节剂(PAM)。
ACS Chem Neurosci. 2024 Sep 24;15(20):3744-54. doi: 10.1021/acschemneuro.4c00465.
3

本文引用的文献

1
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides.MPAM临床前候选药物开发中的挑战:一系列3-氨基氮杂环丁烷衍生酰胺的发现、构效关系及体内特性研究
Bioorg Med Chem Lett. 2017 Jul 1;27(13):2990-2995. doi: 10.1016/j.bmcl.2017.05.014. Epub 2017 May 6.
2
Optimization of M positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology.M 阳性变构调节剂(PAMs)的优化:VU0476406 的发现,一种用于转化药理学的非人灵长类动物体内工具化合物。
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2296-2301. doi: 10.1016/j.bmcl.2017.04.043. Epub 2017 Apr 13.
3
Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP).新型 M4 PAM PET 放射性配体[11C]PF06885190 在非人灵长类动物(NHP)中的特征。
Molecules. 2023 Jun 7;28(12):4612. doi: 10.3390/molecules28124612.
4
SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M PAMs.基于醛氧化酶(AO)代谢的 SAR 研究:新型中枢神经系统穿透性三环 M PAMs 的发现。
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2224-2228. doi: 10.1016/j.bmcl.2019.06.032. Epub 2019 Jun 20.
5
Novel M positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.源自对假定的β-氨基酰胺类配体分子内氢键模式的作用和影响提出质疑的新型 M 阳性变构调节剂。
Bioorg Med Chem Lett. 2019 Feb 1;29(3):362-366. doi: 10.1016/j.bmcl.2018.12.039. Epub 2018 Dec 18.
6
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.变构调节 A 类 G 蛋白偶联受体:靶点、药物及新的概念。
J Med Chem. 2019 Jan 10;62(1):88-127. doi: 10.1021/acs.jmedchem.8b00875. Epub 2018 Aug 28.
7
Cobalt-Catalyzed (Hetero)arylation of Saturated Cyclic Amines with Grignard Reagents.钴催化的饱和环状胺与格氏试剂的(杂)芳基化反应。
Molecules. 2018 Jun 14;23(6):1449. doi: 10.3390/molecules23061449.
Discovery of VU0467485/AZ13713945: An M PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia.
VU0467485/AZ13713945的发现:一种被评估为治疗精神分裂症临床前候选药物的代谢型谷氨酸受体正向变构调节剂
ACS Med Chem Lett. 2016 Dec 16;8(2):233-238. doi: 10.1021/acsmedchemlett.6b00461. eCollection 2017 Feb 9.
4
Challenges in the development of an M PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs.开发一种体内 M PAM 工具化合物的挑战:VU0467154 的发现及紧密类似物意外的药物代谢动力学特征。
Bioorg Med Chem Lett. 2017 Jan 15;27(2):171-175. doi: 10.1016/j.bmcl.2016.11.086. Epub 2016 Nov 30.
5
Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.基于不可烯醇化酮核心的新型强效、可穿透中枢神经系统的M4型正变构调节剂系列的发现与构效关系:处置方面的挑战
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4282-6. doi: 10.1016/j.bmcl.2016.07.042. Epub 2016 Jul 21.
6
Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core.基于5,6-二甲基-4-(哌啶-1-基)噻吩并[2,3-d]嘧啶核心的新型系列高中枢神经系统渗透性M4型正变构调节剂的发现与优化
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3029-3033. doi: 10.1016/j.bmcl.2016.05.010. Epub 2016 May 5.
7
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.M4毒蕈碱受体信号传导改善左旋多巴诱导的异动症模型中的纹状体可塑性缺陷。
Neuron. 2015 Nov 18;88(4):762-73. doi: 10.1016/j.neuron.2015.10.039.
8
Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice.M4毒蕈碱受体的变构激活改善早期有症状的YAC128小鼠的行为和生理改变。
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):14078-83. doi: 10.1073/pnas.1512812112. Epub 2015 Oct 27.
9
Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4).基于平行多参数细胞的荧光成像板读数仪检测分析在毒蕈碱型乙酰胆碱受体4(M4)调节剂鉴定中的应用
J Biomol Screen. 2015 Aug;20(7):858-68. doi: 10.1177/1087057115581770. Epub 2015 Apr 15.
10
Synthesis and pharmacological evaluation of M4 muscarinic receptor positive allosteric modulators derived from VU10004.从 VU10004 中衍生的 M4 毒蕈碱型乙酰胆碱受体正变构调节剂的合成及药理学评价。
ACS Chem Neurosci. 2015 Jun 17;6(6):838-44. doi: 10.1021/acschemneuro.5b00035. Epub 2015 Apr 17.